Stepanova, N., Burdeyna, O., & Driianska, V. (2022). Beneficial pleiotropic effects of atorvastatin in peritoneal dialysis patients withdrawn by author. Atherosclerosis (00219150), 355, N.PAG. https://doi.org/10.1016/j.atherosclerosis.2022.06.878
Chicago Style (17th ed.) CitationStepanova, N., O. Burdeyna, and V. Driianska. "Beneficial Pleiotropic Effects of Atorvastatin in Peritoneal Dialysis Patients Withdrawn by Author." Atherosclerosis (00219150) 355 (2022): N.PAG. https://doi.org/10.1016/j.atherosclerosis.2022.06.878.
MLA (9th ed.) CitationStepanova, N., et al. "Beneficial Pleiotropic Effects of Atorvastatin in Peritoneal Dialysis Patients Withdrawn by Author." Atherosclerosis (00219150), vol. 355, 2022, p. N.PAG, https://doi.org/10.1016/j.atherosclerosis.2022.06.878.